BRM/BRG1 ATP-IN-8
BRM/BRG1 ATP-IN-8 (Compound Cpd14) is an orally active BRG1/BRM ATPase domain inhibitor. BRM/BRG1 ATP-IN-8 exerts antitumor effects by disrupting aberrant chromatin remodeling in cancer cells, inducing apoptosis and growth arrest. BRM/BRG1 ATP-IN-8 is promising for research of BRG1/BRM-dependent malignancies, including hematological cancers, prostate cancer, breast cancer, and Ewing's sarcoma.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2468046-72-0
- Fòrmula: C26H23N5O6S2
- Peso molecular:565.62
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas SWI/SNF Complex
More
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 2468046-72-0
-
Peso molecular 565.62
-
Fòrmula C26H23N5O6S2
-
SMILES
O=C(C1(CC1)C2=NC=CC(C3=CC=CC(C4=CSC(NC(CNC(C5=CN(S(=O)(C)=O)C=C5)=O)=O)=N4)=C3)=C2)O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BRM/BRG1 ATP-IN-8 Related Classifications
HY-178490 Related Classifications
Powered by Bioz